These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7288433

  • 41. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D, Popovic V, Kendereski A, Peino R, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [Abstract] [Full Text] [Related]

  • 42. Urinary GH secretion correlates with plasma GH levels during sleep and GHRH stimulation tests but not during the L-dopa stimulation test in prepubertal children.
    Porquet D, Fjellestad-Paulsen A, Leger J, Simon D, Czernichow P, Evain-Brion D.
    Horm Res; 1993 Nov; 39(1-2):19-24. PubMed ID: 8406335
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.
    van den Berg G, Veldhuis JD, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2460-7. PubMed ID: 8675561
    [Abstract] [Full Text] [Related]

  • 46. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T, Yoshinari M, Okamura K, Ikenoue H, Sato K, Kuroda T, Fujishima M.
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb 20; 67(2):65-74. PubMed ID: 1674920
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
    Carmina E, Lanzara P, Lo Coco R, Longo RA, Jannì A.
    Arch Sci Med (Torino); 1979 Feb 20; 136(3):421-5. PubMed ID: 549547
    [Abstract] [Full Text] [Related]

  • 51. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep 20; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.
    Am J Gastroenterol; 1992 May 20; 87(5):580-3. PubMed ID: 1595643
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.